Market Overview:
The global blepharitis treatment drugs market is expected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of blepharitis, rising awareness about available treatments, and growing demand for combination drug therapy. The global blepharitis treatment drugs market is segmented on the basis of type into antibiotics, steroids, and other drugs. The antibiotics segment is expected to account for the largest share of the global blepharitis treatment drugs market in 2018. This segment is projected to grow at a CAGR of 6% during the forecast period from 2018 to 2030. The growth in this segment can be attributed to increasing awareness about available treatments and rising incidence of bacterial infections leading to blepharitis. On the basis of application, monotherapy accounted for majority share (64%)of total revenue generated by Blephamide products globally followed by combination drug therapy which captured 36%.
Product Definition:
Blepharitis Treatment Drugs are drugs that are used to treat blepharitis. Blepharitis is a condition that causes inflammation of the eyelids. The most common symptom of blepharitis is dry eyes. Blepharitis Treatment Drugs can help relieve the symptoms of blepharitis and improve eye health.
Antibiotics:
Antibiotics Market is expected to grow at a significant rate during the forecast period. The market growth can be attributed to factors such as increasing geriatric population base, rising prevalence of bacterial infection in patients and unhealthy lifestyle practices. Antibiotics are used for treatment against various types of bacteria including acne, bronchitis, ear infections and pneumonia among others. In addition, it is also used against some viruses such as the flu (influenza), chickenpox and hepatitis among others.
Steroids:
Steroids are man-made chemicals that are similar to the body’s natural hormones. They are sometimes prescribed for conditions such as myopia (near sightedness), acne, and hirsutism (excessive hair growth). Steroids can have side effects such as diabetes, heart disease, stroke, and cancer. Long term use of steroids may lead to hormonal imbalance in the body. The most commonly used types of steroids include corticosteroids and anabolic steroids.
Application Insights:
Blepharitis is a chronic eye disorder which affects the eyelids and can be acute or chronic. Acute blepharitis occurs when there is an increase in the inflammation of the eyelid due to bacterial infection or injury. On the other hand, blepharitis patients suffering from chronic inflammation of eyes for more than 2 weeks require treatment with medication to reduce such symptoms as itching, burning sensation and crust formation around eyes.
The combination drug therapy segment dominated this market owing to high prevalence of diseases such as acne vulgaris, rosacea and eczema herpetiformis which are associated with Blepharitis (inflammation of eyelid). For instance, according to a study published by National Rosacea Society in 2017, 90% people who suffer from moderate-to-severe rosacea have some degree of inflammatory blepharitides (IBIL).
Regional Analysis:
North America dominated the global blepharitis treatment drugs market in 2017. The rising prevalence of infectious diseases, increasing geriatric population and better healthcare facilities are some of the major factors responsible for its large share. In addition, rise in cosmetic eyelid surgery is also expected to drive growth during the forecast period.
Asia Pacific is anticipated to witness fastest growth over the forecast period owing to growing awareness about various treatment options and their respective benefits among patients as well as physicians.
The key players operating in this industry have adopted various strategies such as mergers & acquisitions, collaborations with other companies or development of new products for treating blepharitis effectively.
Growth Factors:
- Increasing prevalence of blepharitis
- Growing awareness about the available treatment options for blepharitis
- Rising demand for minimally invasive and non-invasive blepharitis treatments
- Technological advancements in blepharitis treatment drugs and devices
- Availability of government funding and private sector investment for research on new Blepharitis Treatment Drugs
Scope Of The Report
Report Attributes
Report Details
Report Title
Blepharitis Treatment Drugs Market Research Report
By Type
Antibiotics, Steroids, Other
By Application
Monotherapy, Combination Drug Therapy
By Companies
Bausch Health, Allergan, Novartis, LABORATORIES THEA, Akorn, NovaBay Pharmaceuticals, Scope Ophthalmics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
237
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Blepharitis Treatment Drugs Market Report Segments:
The global Blepharitis Treatment Drugs market is segmented on the basis of:
Types
Antibiotics, Steroids, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Monotherapy, Combination Drug Therapy
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bausch Health
- Allergan
- Novartis
- LABORATORIES THEA
- Akorn
- NovaBay Pharmaceuticals
- Scope Ophthalmics
Highlights of The Blepharitis Treatment Drugs Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Antibiotics
- Steroids
- Other
- By Application:
- Monotherapy
- Combination Drug Therapy
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Blepharitis Treatment Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Blepharitis is an inflammation of the eyelid margin. Treatment drugs may include antibiotics, topical ointments, or surgery.
Some of the major players in the blepharitis treatment drugs market are Bausch Health, Allergan, Novartis, LABORATORIES THEA, Akorn, NovaBay Pharmaceuticals, Scope Ophthalmics.
The blepharitis treatment drugs market is expected to register a CAGR of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Blepharitis Treatment Drugs Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Blepharitis Treatment Drugs Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Blepharitis Treatment Drugs Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Blepharitis Treatment Drugs Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Blepharitis Treatment Drugs Market Size & Forecast, 2018-2028
4.5.1 Blepharitis Treatment Drugs Market Size and Y-o-Y Growth
4.5.2 Blepharitis Treatment Drugs Market Absolute $ Opportunity
Chapter 5 Global Blepharitis Treatment Drugs Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Blepharitis Treatment Drugs Market Size Forecast by Type
5.2.1 Antibiotics
5.2.2 Steroids
5.2.3 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Blepharitis Treatment Drugs Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Blepharitis Treatment Drugs Market Size Forecast by Applications
6.2.1 Monotherapy
6.2.2 Combination Drug Therapy
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Blepharitis Treatment Drugs Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Blepharitis Treatment Drugs Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Blepharitis Treatment Drugs Analysis and Forecast
9.1 Introduction
9.2 North America Blepharitis Treatment Drugs Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Blepharitis Treatment Drugs Market Size Forecast by Type
9.6.1 Antibiotics
9.6.2 Steroids
9.6.3 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Blepharitis Treatment Drugs Market Size Forecast by Applications
9.10.1 Monotherapy
9.10.2 Combination Drug Therapy
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Blepharitis Treatment Drugs Analysis and Forecast
10.1 Introduction
10.2 Europe Blepharitis Treatment Drugs Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Blepharitis Treatment Drugs Market Size Forecast by Type
10.6.1 Antibiotics
10.6.2 Steroids
10.6.3 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Blepharitis Treatment Drugs Market Size Forecast by Applications
10.10.1 Monotherapy
10.10.2 Combination Drug Therapy
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Blepharitis Treatment Drugs Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Blepharitis Treatment Drugs Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Blepharitis Treatment Drugs Market Size Forecast by Type
11.6.1 Antibiotics
11.6.2 Steroids
11.6.3 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Blepharitis Treatment Drugs Market Size Forecast by Applications
11.10.1 Monotherapy
11.10.2 Combination Drug Therapy
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Blepharitis Treatment Drugs Analysis and Forecast
12.1 Introduction
12.2 Latin America Blepharitis Treatment Drugs Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Blepharitis Treatment Drugs Market Size Forecast by Type
12.6.1 Antibiotics
12.6.2 Steroids
12.6.3 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Blepharitis Treatment Drugs Market Size Forecast by Applications
12.10.1 Monotherapy
12.10.2 Combination Drug Therapy
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Blepharitis Treatment Drugs Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Blepharitis Treatment Drugs Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Blepharitis Treatment Drugs Market Size Forecast by Type
13.6.1 Antibiotics
13.6.2 Steroids
13.6.3 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Blepharitis Treatment Drugs Market Size Forecast by Applications
13.10.1 Monotherapy
13.10.2 Combination Drug Therapy
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Blepharitis Treatment Drugs Market: Competitive Dashboard
14.2 Global Blepharitis Treatment Drugs Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bausch Health
14.3.2 Allergan
14.3.3 Novartis
14.3.4 LABORATORIES THEA
14.3.5 Akorn
14.3.6 NovaBay Pharmaceuticals
14.3.7 Scope Ophthalmics
